Remi Gaston-Dreyfus - 26 Mar 2021 Form 4 Insider Report for Bionik Laboratories Corp.

Role
Director, 10%+ Owner
Signature
/s/ Remi Gaston-Dreyfus
Issuer symbol
BNKL on OTC
Transactions as of
26 Mar 2021
Net transactions value
$0
Form type
4
Filing time
13 Dec 2021, 15:30:45 UTC
Next filing
13 Dec 2021
SEC
View on sec.gov

Transactions Table

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Ownership Footnotes
transaction BNKL Common Stock, par value $0.001 per share Purchase +135,560 +11% 1,418,194 26 Mar 2021 Shares held through RGD Investissements S.A.S. and Lombard International Assurance SA F1
holding BNKL Common Stock, par value $0.001 per share 61,256 26 Mar 2021 Direct
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 The reporting person, through its affiliate RGD Investissements S.A.S., acquired the shares of common stock for consideration consisting of the forgiveness and satisfaction of an aggregate of $338,904 of wage liabilities of the Issuer's subsidiaries.